Mouwasat Valuation Multiples

Discover revenue and EBITDA valuation multiples for Mouwasat and similar public comparables like Asker Healthcare Group, Krishna Institute, Kpj Healthcare, Option Care Health and more.

Mouwasat Overview

About Mouwasat

Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue.


Founded

1997

HQ

Saudi Arabia

Employees

4.1K

Financials (LTM)

Revenue: $916M
EBITDA: $306M

EV

$3.5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Mouwasat Financials

Mouwasat reported last 12-month revenue of $916M and EBITDA of $306M.

In the same LTM period, Mouwasat generated $381M in gross profit, $306M in EBITDA, and $222M in net income.

Revenue (LTM)


Mouwasat P&L

In the most recent fiscal year, Mouwasat reported revenue of $888M and EBITDA of $316M.

Mouwasat is profitable as of last fiscal year, with gross margin of 42%, EBITDA margin of 36%, and net margin of 26%.

See analyst estimates for Mouwasat
LTMLast FY202320242025202620272028
Revenue$916M$888M$746M$794M$888M
Gross Profit$381M$375M$362M$355M$375M
Gross Margin42%42%49%45%42%
EBITDA$306M$316M$275M$269M$316M
EBITDA Margin33%36%37%34%36%
EBIT Margin26%27%28%24%27%
Net Profit$222M$227M$181M$178M$227M
Net Margin24%26%24%22%26%
Net Debt-$124M---

Financial data powered by Morningstar, Inc.

Mouwasat Stock Performance

Mouwasat has current market cap of $3.4B, and enterprise value of $3.5B.

Market Cap Evolution


Mouwasat's stock price is $16.79.

Mouwasat share price decreased by 1.1% in the last 30 days, and by 17.2% in the last year.

Mouwasat has an EPS (earnings per share) of $1.13.

See more trading valuation data for Mouwasat
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3.5B$3.4B0.7%-1.1%-7.5%-17.2%$1.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Mouwasat Valuation Multiples

Mouwasat trades at 3.9x EV/Revenue multiple, and 11.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Mouwasat

EV / Revenue (LTM)


Mouwasat Financial Valuation Multiples

As of July 17, 2026, Mouwasat has market cap of $3.4B and EV of $3.5B.

Mouwasat has a P/E ratio of 15.1x.

LTMLast FY202320242025202620272028
EV/Revenue3.9x4.0x4.7x4.5x4.0x
EV/EBITDA11.6x11.2x12.9x13.2x11.2x
EV/EBIT15.0x14.8x17.2x18.2x14.8x
EV/Gross Profit9.3x9.4x9.8x10.0x9.4x
P/E15.1x14.8x18.5x18.9x14.8x
EV/FCF30.4x17.1x24.4x15.6x17.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Mouwasat Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Mouwasat Margins & Growth Rates

Mouwasat grew revenue by 9% but EBITDA decreased by 1% in the last fiscal year.

In the most recent fiscal year, Mouwasat reported gross margin of 42%, EBITDA margin of 36%, and net margin of 26%.

See estimated margins and future growth rates for Mouwasat

Mouwasat Margins

Last FY202420252026202720282029
Gross Margin42%45%42%41%
EBITDA Margin36%34%36%32%
EBIT Margin27%24%27%25%
Net Margin26%22%26%23%
FCF Margin23%29%23%12%

Mouwasat Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth9%6%12%9%
Gross Profit Growth6%(2%)6%6%
EBITDA Growth(1%)(2%)18%(1%)
EBIT Growth(1%)(6%)23%(1%)
Net Profit Growth(1%)(2%)27%(1%)
FCF Growth(45%)56%(9%)(45%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Mouwasat Operational KPIs

Mouwasat's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.

Mouwasat's Rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Mouwasat's Rule of X is 54% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Mouwasat
LTMLast FY202320242025202620272028
Rule of 4044%41%---
Bessemer Rule of X61%54%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue2%2%1%1%1%
G&A Expenses to Revenue14%13%3%3%3%
Opex to Revenue-15%21%20%15%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Mouwasat Competitors

Mouwasat competitors include Asker Healthcare Group, Krishna Institute, Kpj Healthcare, Option Care Health, IKS Health, Medicover, Acadia Healthcare, Global Health, Dallah Healthcare and Meinian Onehealth.

Most Mouwasat public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Asker Healthcare Group2.1x2.0x17.1x16.3x
Krishna Institute9.2x8.5x44.2x40.6x
Kpj Healthcare3.8x3.8x15.9x15.7x
Option Care Health0.8x0.8x9.7x9.6x
IKS Health9.7x8.7x28.5x26.9x
Medicover1.8x1.7x11.0x10.5x
Acadia Healthcare1.7x1.7x9.2x9.3x
Global Health8.1x7.7x35.2x35.7x

This data is available for Pro users. Sign up to see all Mouwasat competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Mouwasat

When was Mouwasat founded?Mouwasat was founded in 1997.
Where is Mouwasat headquartered?Mouwasat is headquartered in Saudi Arabia.
How many employees does Mouwasat have?As of today, Mouwasat has over 4K employees.
Is Mouwasat publicly listed?Yes, Mouwasat is a public company listed on Tadawul.
What is the stock symbol of Mouwasat?Mouwasat trades under 4002 ticker.
When did Mouwasat go public?Mouwasat went public in 2009.
Who are competitors of Mouwasat?Mouwasat main competitors include Asker Healthcare Group, Krishna Institute, Kpj Healthcare, Option Care Health, IKS Health, Medicover, Acadia Healthcare, Global Health, Dallah Healthcare, Meinian Onehealth.
What is the current market cap of Mouwasat?Mouwasat's current market cap is $3.4B.
What is the current revenue of Mouwasat?Mouwasat's last 12 months revenue is $916M.
What is the current revenue growth of Mouwasat?Mouwasat revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Mouwasat?Current revenue multiple of Mouwasat is 3.9x.
What is the current EBITDA of Mouwasat?Mouwasat's last 12 months EBITDA is $306M.
What is Mouwasat's EBITDA margin?Mouwasat's last 12 months EBITDA margin is 33%.
What is the current EV/EBITDA multiple of Mouwasat?Current EBITDA multiple of Mouwasat is 11.6x.
What is the current FCF of Mouwasat?Mouwasat's last 12 months FCF is $116M.
What is Mouwasat's FCF margin?Mouwasat's last 12 months FCF margin is 13%.
What is the current EV/FCF multiple of Mouwasat?Current FCF multiple of Mouwasat is 30.4x.
How many companies Mouwasat has acquired to date?Mouwasat hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Mouwasat has invested to date?Mouwasat hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Mouwasat

Lists including Mouwasat

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial